Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock At Cost [Member]
Accumulated Other Comprehensive Loss [Member]
Retained Earnings (Accumulated Deficit) [Member]
Total
Balance at Feb. 01, 2020 $ 32 $ 345,102 $ (230,169) $ (1,479) $ (108,971) $ 4,515
Balance (in shares) at Feb. 01, 2020 3,226   (1,409)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 0 0 $ 0 0 (6,306) (6,306)
Other comprehensive income 0 0 0 6 0 6
Vested restricted shares $ 0 (9) $ 0 0 0 (9)
Vested restricted shares (in shares) 4   (1)      
Common stock issued- Director grants $ 0 243 $ 0 0 0 243
Common stock issued- Director grants (in shares) 6   0      
Amortization of unearned compensation/restricted stock amortization $ 0 285 $ 0 0 0 285
Balance at Aug. 01, 2020 $ 32 346,457 $ (230,169) (1,473) (115,277) (430)
Balance (in shares) at Aug. 01, 2020 3,236   (1,410)      
Balance at May. 02, 2020 $ 32 346,442 $ (230,169) (1,476) (114,377) 451
Balance (in shares) at May. 02, 2020 3,236   (1,410)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 0 0 $ 0 0 (899) (899)
Other comprehensive income 0 0 0 3 0 3
Issuance of warrants 0 0 0 0 0 0
Vested restricted shares $ 0 0 $ 0 0 0 0
Vested restricted shares (in shares) 0   0      
Common stock issued- Director grants $ 0 0 $ 0 0 0 0
Common stock issued- Director grants (in shares) 0   0      
Amortization of unearned compensation/restricted stock amortization $ 0 15 $ 0 0 0 15
Balance at Aug. 01, 2020 $ 32 346,457 $ (230,169) (1,473) (115,277) (430)
Balance (in shares) at Aug. 01, 2020 3,236   (1,410)      
Balance at Jan. 30, 2021 $ 33 346,495 $ (230,169) (2,007) (112,863) 1,489
Balance (in shares) at Jan. 30, 2021 3,337   (1,410)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 0 0 $ 0 0 (1,335) (1,335)
Other comprehensive income 0 0 0 0 0 0
Issuance of warrants $ 2 0 (1) 0 0 1
Issuance of warrants (in shares) 138          
Sale of shares, net of expenses $ 4 12,227 $ 0 0 0 12,231
Sale of shares, net of expenses (in shares) 417   0      
Exercise of stock options $ 0 51 $ 0 0 0 51
Exercise of stock options (in shares) 2   0      
Common stock issued- Director grants $ 0 184 $ 0 0 0 184
Common stock issued- Director grants (in shares) 9   0      
Amortization of unearned compensation/restricted stock amortization $ 0 59 $ 0 0 0 59
Balance at Jul. 31, 2021 $ 39 359,016 $ (230,170) (2,007) (114,198) 12,680
Balance (in shares) at Jul. 31, 2021 3,903   (1,410)      
Balance at May. 01, 2021 $ 39 358,749 $ (230,170) (2,007) (114,280) 12,332
Balance (in shares) at May. 01, 2021 3,889   (1,410)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 0 0 $ 0 0 82 82
Issuance of warrants $ 0 0 0 0 0 0
Issuance of warrants (in shares) 3          
Exercise of stock options $ 0 51 $ 0 0 0 51
Exercise of stock options (in shares) 2   0      
Common stock issued- Director grants $ 0 184 $ 0 0 0 184
Common stock issued- Director grants (in shares) 9   0      
Amortization of unearned compensation/restricted stock amortization $ 0 31 $ 0 0 0 31
Balance at Jul. 31, 2021 $ 39 $ 359,016 $ (230,170) $ (2,007) $ (114,198) $ 12,680
Balance (in shares) at Jul. 31, 2021 3,903   (1,410)